SEARCH:
Clinical Trials Update: Oct. 23, 2009

Clinical Trials Update: Oct. 23, 2009

Related News from HealthDay
Trial Data on Anti-Seizure Drug Might Have Been Manipulated: Report
Clinical Trials Update: Nov. 11, 2009
Clinical Trials Update: Nov. 10, 2009
Clinical Trials Update: Nov. 9, 2009
Clinical Trials Update: Nov. 6, 2009
Clinical Trials Update: Nov. 5, 2009
Health News Archives
   

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

Ragweed Allergy

This study will evaluate the safety and effectiveness of an investigational drug. You must be 18 to 50 and have a history of ragweed allergy to qualify.

The research site is in Houston, Texas.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/allergies.aspx.

-----

Atrial Fibrillation

This study of atrial fibrillation is recruiting candidates. The research site is in Philadelphia, Penn.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/atrial_fibrillation.aspx.

-----

Psoriasis

This study will evaluate an investigational medication for psoriasis, a disorder that affects the skin and joints.

The research site is in Baltimore, Md.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/psoriasis.aspx.

-----

Copyright 2009 ClinicalConnection.com. All rights reserved.

 

Copyright © 2009 ScoutNews, LLC. All rights reserved.


Over 6 million items at your fingertips! Enter a keyword or highlight a category to search or browse at your leisure!
Search by Category

Rocky Mount Telegram | Weather | Sports | Life | Business News | Opinions | Classifieds | Sitemap
Rocky Mount Cars | Rocky Mount Jobs | Rocky Mount Real Estate

Copyright Sat Nov 21 17:16:40 EST 2009 Rocky Mount Telegram All rights reserved. - Rocky Mount Telegram - Our Partners

By using this service, you accept the terms of our visitor agreement and privacy policy. About our ads.
Registered site users, you may edit your profile.
Having trouble? Visit our help & FAQ